Omnes, M Capital Partners lead €5m round for Therapixel

Following the investment, the founder of Mauna Kea Technologies, Sacha Loisea, will join the board as chairman. Omnes associate Maximilien Fournier-Sourdille and M Capital investment manager Yoann Bonnamour will also join the board. Co-founder Olivier Clatz will be leaving the company and the current CTO and co-founder Pierre Fillard has been appointed as CEO until a new chief executive joins.

The fresh capital will be used to deploy Therapixel's breast cancer screening software and to recruit for new talent.

Previous funding
Paca Investissement, IT-Translation and Conseil Plus Gestion invested €600,000 in Therapixel in a seed round in 2015.

The company also won the Dream Digital Mammography Challenge in 2017, winning €1.2m in prize money.

Company
Founded in 2013 by two former researchers at the French National Research Institutre for the Digital Sciences, Therapixel is developing an AI-based service for assisting radiologists in breast cancer screening.

People
M Capital Partners – Yoann Bonnamour (senior associate).
Omnes Capital – Maximilien Fournier-Sourdille (associate).
Therapixel – Peirre Fillard (co-founder, CEO); Sacha Loisea (chairman).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• France
• Technology
• Venture
• Omnes Capital
• healthcare